Offering personalised ovarian cancer risk prediction to women shows that 98 percent of participants felt less worried after finding out their ovarian cancer risk status, according to a study led by Queen Mary University of ...
May 19, 2020
0
5
Over the last decade researchers have become concerned about a possible link between a benign gynecologic lesion called endosalpingiosis (ES) and ovarian cancer. However, using a diagnostic method typically reserved for specimens ...
May 13, 2020
0
0
Certain genetic changes, termed "pathogenic variants," substantially increase risk for cardiovascular disease and cancer—the leading causes of death—but testing to identify individual carriers is not part of current clinical ...
May 1, 2020
0
15
An international research team, led by scientists from Mater Research—The University of Queensland, have discovered they can overcome chemotherapy resistance in an ovarian cancer subtype by using low doses of a drug which ...
Apr 16, 2020
0
332
A class of experimental cancer drugs called BET inhibitors have shown promise for treating cancers of the blood, but can induce toxic side effects. Now Yale researchers have found a new inhibitor that in animal studies demonstrates ...
Apr 16, 2020
0
829
An active immune system plays an important role in stopping cancer progression by identifying tumor cells and targeting them for destruction. Any deviation in the normal activities of the immune system could lead to accelerated ...
Apr 14, 2020
0
264
An international study involving researchers from QIMR Berghofer Medical Research Institute has found women who breastfeed their babies may lower their risk of developing ovarian cancer by almost 25 percent.
Apr 3, 2020
0
5
Malignant ovarian cancer is insidious: Known and feared for vague and uncharacteristic symptoms that often mean the disease is discovered so late that on average only four out of six patients are still alive after five years. ...
Mar 26, 2020
0
8
About 1 in 40 postmenopausal women diagnosed with breast cancer before age 65 have cancer-associated mutations in their BRCA1 or BRCA2 genes, according to a Stanford-led study of more than 4,500 participants in the long-running ...
Mar 10, 2020
0
5
It's an ordinarily overcast day, but the artificial lights of the lab radiate a crude brightness for Professor Stephen Taylor and his team.
Feb 20, 2020
0
5
